Despite the significant mortality associated with status epilepticus (SE), little is known concerning the exact pathophysiological basis of death. A major aim of this proposal is to investigate the effects of SE on the central nervous system (CNS) and cardiovascular system (CVS) and determine the causes of mortality associated with SE. Preliminary data from this study have provided the first electrophysiological data on SE patients just prior to and at the time of death, and data on the effects of SE on CVS function. These findings identified two distinct cardiovascular patterns of mean arterial pressure and rate preceding death in SE. Our research also demonstrated that previously unrecognized CNS and CVS hyper- excitability occurs after SE in a significant percent of patients. We have identified After SE Ictal Discharges (ASIDS) and abnormal evoked potentials (EPs) as electrophysiological high risk markers for a hyper- excitable CNS state. Non-convulsive SE were also demonstrated in up to 10% of comatose patients without overt seizure activity. Preliminary results from this study suggested that ASIDS is a predictive indicator of abnormal cardiac function and are associated with increased cardiac arryhythmogenicity. This research project is focused on critically evaluating the pathophysiology of SE by obtaining carefully controlled physiological data on SE in humans. CENTRAL HYPOTHESES will be tested by accomplishing the following Specific Aims. 1. Develop optimal criteria for detecting and evaluating the temporal occurrence of ASIDS; 2. Determine the temporal relationship of ASIDS and cardiac conduction and/or functional abnormalities that can precipitate cardiac arrest or injury; 3. Evaluate the role of EPS in predicting SE patients at high risk of cardiac death. 4. Determine CNS and CVS functional abnormalities prior to death and correlate with pathologic findings; 5. Determine the frequency of occurrence and the clinical presentation of unrecognized non-convulsive SE (NCSE) in comatose patients; 6. Establish a prospective data base of clinical CNS and CVS data in a large population of adult SE patients and correlate the functional state of the CNS and CVS with other clinical and laboratory values. By coordinating neurologic and cardiac electrophysiological monitoring with pathological, laboratory, and clinical evaluations in a controlled, prospective, population-based data base, this study may provide the first insights into the causes of death and morbidity from SE in man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS025630-11A1
Application #
6302784
Study Section
Project Start
2000-02-23
Project End
2001-01-31
Budget Start
Budget End
Support Year
11
Fiscal Year
2000
Total Cost
$140,288
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Deshpande, Laxmikant S; Sombati, Sompong; Blair, Robert E et al. (2007) Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 411:11-6
Deshpande, Laxmikant S; Blair, Robert E; Nagarkatti, Nisha et al. (2007) Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus. Exp Neurol 204:705-13
Falenski, K W; Blair, R E; Sim-Selley, L J et al. (2007) Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146:1232-44
Deshpande, Laxmikant S; Blair, Robert E; Ziobro, Julie M et al. (2007) Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur J Pharmacol 558:52-9
Carter, Dawn S; Haider, S Naqeeb; Blair, Robert E et al. (2006) Altered calcium/calmodulin kinase II activity changes calcium homeostasis that underlies epileptiform activity in hippocampal neurons in culture. J Pharmacol Exp Ther 319:1021-31
Blair, Robert E; Deshpande, Laxmikant S; Sombati, Sompong et al. (2006) Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 317:1072-8
DeLorenzo, Robert J; Sun, David A; Deshpande, Laxmikant S (2006) Erratum to ""Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy."" [Pharmacol. Ther. 105(3) (2005) 229-266] Pharmacol Ther 111:288-325
DeLorenzo, Robert J (2006) Epidemiology and clinical presentation of status epilepticus. Adv Neurol 97:199-215
Penberthy, L T; Towne, A; Garnett, L K et al. (2005) Estimating the economic burden of status epilepticus to the health care system. Seizure 14:46-51
Delorenzo, Robert J; Sun, David A; Deshpande, Laxmikant S (2005) Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther 105:229-66

Showing the most recent 10 out of 25 publications